View Older Stories View More Recent Stories
-
nTIDE December 2020 Jobs Report: COVID Surge Slows Recovery for People with Disabilities
-
End-of-year unemployment data shows need for continued support for workers
-
Tech Hiring Stands Out in December Jobs Report
-
'This is not our fault': Pandemic job losses fall hardest on hospitality workers
-
Renault to revive bestselling cars with electric makeover - sources
-
"Clocking Out" Released by Careerminds Outplacement CEO
-
Fed's Clarida sees 'impressive' year ahead for U.S. economy
-
Canada loses more jobs than expected in December, lockdowns darken outlook
-
U.S. Lost 140,000 Jobs in December
-
New Commerzbank CEO prepares road ahead with $1.8 billion write-off
-
U.S. economy loses jobs as COVID-19 hammers restaurants, bars
-
U.S. service sector regains speed in December - ISM survey
-
U.S. labor market recovery faltering; layoffs hit record in 2020
-
Walgreens maintains full-year profit growth forecast; shares rise
-
Exclusive: Portugal confident it will get EU green light for TAP rescue plan in first quarter
-
Minutes of the Federal Open Market Committee December 15-16, 2020
-
Georgia results could pave way for quick additional U.S. pandemic support
-
French govt vigilant over Michelin job cuts, spokesman says
-
U.S. private payrolls post first decline in eight months as COVID-19 cases skyrocket
-
December Private Sector Jobs Surprise to Downside with Decrease of 123 Thousand
-
ADP National Employment Report: Private Sector Employment Decreased by 123,000 Jobs in December
-
Autolus Therapeutics provides business outlook for 2021 & 2022
-
Autolus Therapeutics provides business outlook for 2021 & 2022
-
Michelin to cut up to 2,300 jobs over three years
-
Comerica Bank's California Index Ticked Higher
-
Comerica Bank's Texas Index Improved
-
Our New Year’s Resolution: Let’s Buy Canadian
-
Comerica Bank's Michigan Index Inched Higher
-
Calithera Biosciences (CALA) CANTATA Study of Telaglenastat in Renal Cell Carcinoma Did Not Achieve Primary Endpoint
-
Calithera Biosciences Reports CANTATA Study of Telaglenastat in Renal Cell Carcinoma Did Not Achieve Primary Endpoint
-
U.S. cities, left behind in COVID-19 aid, look for lifeline in Biden era
-
Patent Infringement and License Royalties Are Mounting Concerns Amidst Strong Consumer Electronics Market
-
Patent Infringement and License Royalties Are Mounting Concerns Amidst Strong Consumer Electronics Market
-
420 with CNW — Cannabis Delivery Firms Thrive Despite COVID-19 by Implementing Models Used by Black Market
-
COVID-19 shook, rattled and rolled the global economy in 2020
-
Exxon signals up to $20 billion writedown to overwhelm 4th-qtr gains in oil, chemicals
-
Lendio to Hire 500 Employees to Continue Its Mission of Saving Small Businesses
-
Lendio to Hire 500 Employees to Continue Its Mission of Saving Small Businesses
-
Asian business confidence gains steam, pandemic still top risk: Thomson Reuters/INSEAD survey
-
American Airlines begins return of workers after payroll relief
-
Remittance resurgence a tonic but no cure for sickly emerging economies
-
Ark Restaurants Announces Financial Results for the Fourth Quarter and Fiscal Year Ended 2020
-
Calavo Growers, Inc. Announces Fourth Quarter and Fiscal 2020 Financial Results
-
Retail Fuels Industry Urges Northeastern States to Refrain from Adopting TCI
-
U.S. consumers struggled to access credit, handle emergency costs in 2020, study shows
-
MetroPlusHealth Teams Up With Artists and Creators to Help Unemployed Asian American New Yorkers Impacted by COVID-19
-
Ennis, Inc. Reports Results for the Three and Nine Months Ended November 30, 2020 and Declares Quarterly Dividend
-
Iconic Washington Monument shut after visit by COVID-infected Interior secretary
-
U.S. lawmakers consider aid for aerospace workers in COVID-19 bill
-
Rio Tinto names Stausholm as CEO in surprise pick after cave destruction
